FDA approved Varubi (rolapitant) to prevent delayed phase chemotherapy-induced nausea and vomiting.
EDITH MITCHELL was named president of the National Medical Association, at the organization's 113th annual convention and scientific assembly in Detroit Aug 4. Mitchell is a professor of medical oncology at Thomas Jefferson University.
Cancer researcher Sidney Mirvish died at age 86. His research into nitrosamines and carcinogenesis led to changes in the way lunch meats, hot dogs and sausages were made.
FDA granted priority review for MCNA, developed by Telesta Therapeutics Inc.
FDA granted Orphan Drug Designation for MTG-201, a therapy targeting Dickkopf-3 gene defects in various cancers, for the treatment of malignant mesothelioma.
The American Society of Clinical Oncology issued an updated policy statement on genetic and genomic testing for cancer susceptibility.
FDA granted Orphan Drug Designation to Toca 511 & Toca FC, an investigational immunotherapy treatment for glioblastoma developed by Tocagen.
The European Commission granted a marketing authorization for Unituxin (dinutuximab) for the treatment of high-risk neuroblastoma in patients aged 12 months to 17 years, who have previously received induction chemotherapy and achieved at least a partial response, followed by myeloablative therapy and autologous stem cell transplantation.
THE CANCER PREVENTION AND RESEARCH INSTITUTE OF TEXAS awarded seven grants through its academic research program. The grants, totaling $23 million, support the recruitment of seven cancer scientists to academic institutions in Texas, including two distinguished senior researchers.
ECOG-ACRIN opened the NCI-MATCH precision medicine trial, the largest, most scientifically rigorous precision medicine trial in cancer to date.
